← Back to Patent Explorer
US4200435A Expired / Lapsed US ⏱️ 0.0 years remaining

Determination of glycosylated hemoglobin in blood

Assignee: Abbott Laboratories
•
Filing: 1978-12-26
•
Granted: 1980-04-29
•
Expires: 1998-12-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for determining glycosylated hemoglobin in blood samples which involves liberating hemoglobins from red blood cells by chemical or physical means and reacting non-glycosylated hemoglobin with an allosteric site binding substance which reacts with the allosteric binding site of non-glycosylated hemoglobin and thereby alters the distribution between allosteric forms of the hemoglobins and measuring the change. This method is useful in monitoring glucose metabolism for detecting and controlling diabetes.

Inventors

  • 👤 Stephen D. Stroupe
  • 👤 Edwin G. Moore

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:24
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/723; H; H04; H04M; H04M19/00; H04M19/02; H04M19/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 60 words
A method for determining glycosylated hemoglobin in a blood sample comprising chemically or physically treating the blood sample to release glycosylated and non-glycosylated hemoglobins from red blood cells, intermixing an allosteric effector site binding substance which binds to the allosteric effector site of the non-glycosylated hemoglobin thereby changing the distribution between allosteric forms of the hemoglobins, and measuring the change.
Claim 2
Independent Claim 60 words
A method for determining glycosylated hemoglobin in a blood sample comprising chemically or physically treating the blood sample to release glycosylated and non-glycosylated hemoglobins from red blood cells, intermixing an allosteric effector site binding substance which binds to the allosteric effector site of the non-glycosylated hemoglobin thereby changing the distribution between allosteric forms of the hemoglobins, and measuring the change.
Claim 3
Dependent Claim 19 words
The method according to claim 1 wherein the heme moiety of the hemoglobin is coordinated with a hemebinding ligand.
Claim 4
Dependent Claim 13 words
The method according to claim 1 wherein the hemoglobins are oxidized to methemoglobin.
Claim 5
Dependent Claim 21 words
The method according to claim 1 wherein the blood sample is lysed with a detergent to release hemoglobins from blood cells.
Claim 6
Dependent Claim 29 words
The method according to claim 1 wherein the change in distribution of the allosteric forms of hemoglobin is measured by absorption spectroscopy in the range of 450 nm-700 nm.
Claim 7
Independent Claim 81 words
A method for determining glycosylated hemoglobin in a blood sample comprising: (a) lysing red blood cells to release glycosylated and nonglycosylated hemoglobins; (b) oxidizing the hemoglobins to methemoglobins and coordinating the heme moiety with a heme-binding ligand; (c) intermixing an allosteric effector site binding substance which binds to the allosteric effector site of the nonglycosylated hemoglobin thereby changing the distribution between allosteric forms of the hemoglobins; and (d) measuring the change by adsorption spectroscopy in the range of 450 nm-700 nm.
Claim 8
Independent Claim 81 words
A method for determining glycosylated hemoglobin in a blood sample comprising: (a) lysing red blood cells to release glycosylated and nonglycosylated hemoglobins; (b) oxidizing the hemoglobins to methemoglobins and coordinating the heme moiety with a heme-binding ligand; (c) intermixing an allosteric effector site binding substance which binds to the allosteric effector site of the nonglycosylated hemoglobin thereby changing the distribution between allosteric forms of the hemoglobins; and (d) measuring the change by adsorption spectroscopy in the range of 450 nm-700 nm.

References Cited (Backward Citations)

US3918905A Cited
US3958560A Cited
US3964865A Cited
US4077772A Cited
US4142858A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-04-29 1983-10-29 1984-04-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-04-29 1987-10-29 1988-04-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-04-29 1991-10-29 1992-04-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag